High level human to mosquito transmission of Plasmodium vivax during CHMI
The availability of a tractable in vivo system to study human-to-mosquito transmission of P. vivax would represent a major asset for exploring parasite biology, and for evaluating transmission-blocking interventions. Here we describe progress in our ongoing work using a bank of well-characterised P. vivax-infected red blood cells to undertake induced blood stage malaria infection (IBSM) in malaria naïve volunteers. We have previously reported the ability to observe growth and drug clearance of parasitemia using a qPCR targeting the 18S rDNA gene, and changes in gametocytemia by qRT-PCR targeting pvs25. By optimising several aspects of the experimental conditions we now report reproducible high level transmission of P. vivax infection to Anopheles mosquitoes. Transmission was achieved after either direct skin feeding assay (DFA) or direct membrane feeding assay (DMFA) from 75% of participants, with a prevalence of infection up 63% after DFA and up 12% after DMFA. Using optimised membrane feeding assays, ~93% of the mosquitoes dissected ~8 days after feeding were infected, with a range of 1 – 10 oocysts/midgut. When salivary glands were dissected ~15 days after feeding assay, the yield of sporozoites/infected mosquito was ~4,300. Transmission success was related to the level of gametocytemia present in the volunteers at the time of feeding assay as determined by pvs25 qRT-PCR.